Catalog
Help
Build your portfolio here
Enter the quantity next to the stocks you need — your portfolio will be created automatically.
Quick screener: filter by category and recommendation, review fundamentals, metrics and company profiles.
| Company | Category | Price | Δ% | Div% | Vol20 | EPS(TTM) | QoQ | EPS(SPR) | Style | Horizon | Pot. | Risk | Recommendation | Portfolio |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abivax (ABVX) | Biotech | 116.60 | -2.39% | 0.0% | 1.7% | -5.84 | -200.0% | 24.9% | Growth | Medium | 30 | 80 | Sell |
|
| Alnylam Pharmaceuticals (ALNY) | Biotech | 247.79 | -3.96% | 0.0% | 2.8% | 6.10 | 10.6% | -25.8% | Growth | Medium | 53 | 67 | Hold |
|
| Apogee Therapeutics (APGE) | Biotech | 135.07 | 0.00% | 0.0% | 0.0% | -4.34 | 0.0% | -6.5% | Growth | Long | 33 | 70 | Sell |
|
| Arrowhead Pharmaceuticals (ARWR) | Biotech | 82.46 | -0.20% | 0.0% | 1.8% | -2.24 | 2.1% | -6.3% | Growth | Medium | 51 | 70 | Hold |
|
| Bio-Techne (TECH) | Biotech | 72.25 | +0.01% | 0.6% | 0.1% | 1.17 | 3.1% | 0.2% | Growth | Medium | 62 | 40 | Buy |
|
| BioCryst Pharmaceuticals (BCRX) | Biotech | 8.13 | -7.61% | 0.0% | 2.7% | -1.44 | 39.5% | 0.0% | Growth | Medium | 44 | 70 | Sell |
|
| Biohaven (BHVN) | Biotech | 12.77 | -14.89% | 0.0% | 5.1% | -4.64 | 0.0% | -19.6% | Growth | Medium | 30 | 75 | Sell |
|
| BioMarin Pharmaceutical (BMRN) | Biotech | 64.64 | +0.36% | 0.0% | 1.6% | 0.38 | 29.2% | 26.7% | Growth | Medium | 76 | 39 | Buy |
|
| BioNTech (BNTX) | Biotech | 96.39 | -1.77% | 0.0% | 5.5% | -6.73 | -12.0% | -54.3% | Growth | Medium | 34 | 75 | Sell |
|
| CAMP4 Therapeutics (CAMP) | Biotech | 4.26 | -1.62% | 0.0% | 5.1% | -2.23 | 37.5% | -174.3% | Growth | Medium | 38 | 70 | Hold |
|
| Celcuity (CELC) | Biotech | 86.64 | -3.82% | 0.0% | 2.5% | -4.29 | 0.0% | -24.1% | Growth | Medium | 29 | 76 | Sell |
|
| Centessa Pharmaceuticals (CNTA) | Pharma | 40.50 | 0.00% | 93.8% | 0.0% | -1.78 | 0.0% | -36.8% | Growth | Medium | 30 | 71 | Sell |
|
| Cidara Therapeutics (CDTX) | Biotech | 221.38 | 0.00% | 0.0% | 0.0% | -11.78 | 0.0% | 0.0% | Growth | Medium | 30 | 80 | Sell |
|
| Corcept Therapeutics (CORT) | Biotech | 115.46 | -0.21% | 0.0% | 1.5% | 0.52 | 55.3% | 1383.3% | Growth | Medium | 73 | 34 | Buy |
|
| Corvus Pharmaceuticals (CRVS) | Biotech | 13.09 | -1.84% | 0.0% | 2.4% | -0.64 | 0.0% | -19.4% | Growth | Medium | 32 | 73 | Sell |
|
| CPRX (CPRX) | Healthcare | 31.49 | 0.00% | 0.0% | 0.0% | 1.80 | -2.1% | 15.6% | Growth | Medium | 63 | 40 | Buy |
|
| Crinetics Pharmaceuticals (CRNX) | Biotech | 84.95 | 0.00% | 0.0% | 0.1% | -5.05 | 134.0% | 0.0% | Growth | Medium | 70 | 60 | Hold |
|
| Definium Therapeutics (DFTX) | Biotech | 37.74 | -0.67% | 0.0% | 2.8% | -3.44 | 0.0% | -166.2% | Growth | Medium | 39 | 76 | Sell |
|
| Dianthus Therapeutics (DNTH) | Biotech | 105.62 | -1.33% | 0.0% | 2.2% | -0.13 | 64.4% | 0.0% | Growth | Long | 60 | 50 | Hold |
|
| Disc Medicine (IRON) | Biotech | 75.02 | -1.95% | 0.0% | 1.2% | -6.60 | 0.0% | 9.9% | Growth | Medium | 49 | 66 | Hold |
|
| EyePoint Pharmaceuticals (EYPT) | Healthcare | 4.13 | -4.95% | 0.0% | 15.8% | -3.74 | -27.2% | -7.9% | Value | Medium | 4 | 90 | Sell |
|
| Forte Biosciences (FBRX) | Biotech | 76.99 | 0.00% | 0.0% | 0.0% | -4.59 | 0.0% | 10.2% | Growth | Medium | 70 | 69 | Hold |
|
| ImmunityBio (IBIO) | Biotech | 1.25 | -1.19% | 0.0% | 2.6% | -0.33 | -100.0% | 39.0% | Growth | Medium | 20 | 85 | Sell |
|
| Immunovant (IMVT) | Biotech | 37.81 | -2.43% | 0.0% | 1.6% | -2.82 | 0.0% | -19.3% | Growth | Medium | 40 | 70 | Sell |
|
| Incyte (INCY) | Pharma | 123.96 | -1.63% | 0.0% | 1.6% | 8.13 | 31.5% | 43.7% | Growth | Medium | 72 | 35 | Buy |
|
| Intellia Therapeutics (NTLA) | Biotech | 11.83 | -3.09% | 0.0% | 4.2% | -3.36 | -49.1% | -0.1% | Growth | Medium | 30 | 80 | Sell |
|
| Ionis Pharmaceuticals (IONS) | Biotech | 54.99 | -1.84% | 0.0% | 0.0% | -3.46 | 8.9% | 0.0% | Growth | Long | 24 | 75 | Sell |
|
| Jazz Pharmaceuticals (JAZZ) | Biotech | 240.40 | -0.38% | 0.0% | 1.8% | 15.20 | 13.0% | -7.6% | Balanced | Medium | 64 | 40 | Buy |
|
| Kura Oncology (KURA) | Biotech | 11.73 | -2.98% | 0.0% | 3.9% | -3.37 | 14.3% | 12.2% | Growth | Medium | 66 | 63 | Buy |
|
| Kymera Therapeutics (KYMR) | Biotech | 117.07 | +1.42% | 0.0% | 2.3% | -3.25 | 89.1% | 13.0% | Growth | Long | 70 | 64 | Hold |
|